Glibenclamide Nanocrystals for Bioavailability Enhancement: Formulation Design, Process Optimization, and Pharmacodynamic Evaluation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pharmaceutical Innovation

• Publication date

  2014-06-26

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s12247-014-9189-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Application of Plackett-Burman screening design for preparing glibenclamide nanoparticles for dissolution enhancement

  2013cited by this paper
• Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats.

  2012cited by this paper
• Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.

  2011cited by this paper
• Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.

  2011cited by this paper
• Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.

  2011cited by this paper
• Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening.

  2011cited by this paper
• Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.

  2011cited by this paper
• Preparation and In Vivo Evaluation of Self-Nanoemulsifying Drug Delivery System (SNEDDS) Containing Ezetimibe

  2011cited by this paper
• Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.

  2010cited by this paper
• Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization

  2010cited by this paper
• Optimization of formulation and process variable of nanosuspension: An industrial perspective.

  2010cited by this paper
• SMEDDS of Glyburide: Formulation, In Vitro Evaluation, and Stability Studies

  2009cited by this paper
• Scanning probe microscopy method for nanosuspension stabilizer selection.

  2009cited by this paper
• Co-solvent solubilization of some poorly-soluble antidiabetic drugs

  2009cited by this paper
• Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

  2008cited by this paper
• Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies.

  2008cited by this paper
• Formulation of Nanosuspensions of Albendazole for Oral Administration

  2008cited by this paper
• Improved Bioavailability of Albendazole Following Oral Administration of Nanosuspension in Rats

  2007cited by this paper
• Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

  2004cited by this paper
• Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS.

  2003cited by this paper
• The bioavailability of glyburide (glibenclamide) under fasting and feeding conditions: a comparative study

  2001cited by this paper
• Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas

  2001cited by this paper

• Spanlastics-Loaded Buccal Films for Improved Olmesartan Delivery and Sustained Hypertension Management: Formulation, Statistical Optimization, In Vitro and In Vivo Evaluation

  2026cites this paper
• Enhanced buccal bioavailability of olmesartan through ultradeformable bilosomes loaded film: a novel approach for hypertension management.

  2026cites this paper
• Navigating translational research in nanomedicine: A strategic guide to formulation and manufacturing.

  2025cites this paper
• Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions

  2024cites this paper
• Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats.

  2024cites this paper
• DEVELOPMENT, OPTIMIZATION AND IN VITRO CHARACTERIZATION OF HALOPERIDOL NANOCRYSTALS USING 32 FACTORIAL DESIGN

  2024cites this paper
• Nano-crystallization of flubendazole for enhanced dissolution rate and improved in vivo efficacy against Trichinella spiralis

  2023cites this paper
• Glibenclamide–malonic acid cocrystal with an enhanced solubility and bioavailability

  2022cites this paper
• Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye.

  2022cites this paper
• Lutein-Loaded Solid Lipid Nanoparticles for Ocular Delivery: Statistical Optimization and Ex Vivo Evaluation

  2021cites this paper
• Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers

  2021cites this paper
• Solubility and Dissolution Study of Prochlorperazine Maleate Nanoparticle Prepared by Design of Experiment

  2021cites this paper
• Lutein-Loaded Solid Lipid Nanoparticles for Ocular Delivery: Statistical Optimization and Ex Vivo Evaluation

  2021cites this paper
• Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions

  2020cites this paper
• A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability

  2020cites this paper
• Spray dried solid dispersion of repaglinide using hypromellose acetate succinate: in vitro and in vivo characterization

  2020cites this paper
• Characterizing and Exploring the Differences in Dissolution and Stability Between Crystalline Solid Dispersion and Amorphous Solid Dispersion

  2020cites this paper
• Pulmonary Delivery of Linezolid Nanoparticles for Treatment of Tuberculosis: Design, Development, and Optimization

  2020cites this paper
• Inhalable linezolid loaded PLGA nanoparticles for treatment of tuberculosis: Design, development and in vitro evaluation

  2020cites this paper
• Lercanidipine Hydrochloride Nanocrystals: Impact of Shear and Milling on Particle Size Reduction to Enhance Dissolution and Saturation Solubility

  2020cites this paper
• Pulmonary Delivery of Linezolid Nanoparticles for Treatment of Tuberculosis: Design, Development, and Optimization

  2020cites this paper
• Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles

  2019cites this paper
• Formulation and Evaluation of a Novel Oral Oil-Based Suspension Using Micro-environmental pH-Modifying Solid Dispersion

  2019cites this paper
• Synthesis of glibenclamide cocrystals through grinding methods

  2018cites this paper
• Assessment of nanocomposites vs. amorphous solid dispersions for dissolution enhancement of bcs class ii drugs

  2017influential citation
• Optimization by experimental design of grinding process variables for glibenclamide nanoparticles formation

  2017cites this paper
• From synthesis to formulation of gliclazide and glibenclamide cocrystal pharmaceutical solid dosage forms

  2017cites this paper
• A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.

  2017cites this paper
• Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals

  2016cites this paper
• Formulation of nimodipine nanocrystals for oral administration

  2016cites this paper
• Nanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective

  2016cites this paper
• New Nanometric Solid Dispersions of Glibenclamide in Neusilin® UFL2

  2016cites this paper
• Formulation of nimodipine nanocrystals for oral administration

  2015cites this paper
• Development and optimization of press coated tablets of release engineered valsartan for pulsatile delivery

  2015cites this paper